Cooperative interactions between RB and p53 regulate cell proliferation, cell senescence, and apoptosis in human vascular smooth muscle cells from atherosclerotic plaques

Circulation Research
M R BennettP L Weissberg

Abstract

Compared with vascular smooth muscle cells (VSMCs) from normal vessels, VSMCs from human atherosclerotic plaques proliferate more slowly, undergo earlier senescence, and demonstrate higher levels of apoptosis in culture. The tumor suppressor genes p105RB (retinoblastoma, acting through the E2F transcription factor family) and p53 regulate cell proliferation, cell senescence, and apoptosis in many cell types. We have therefore determined whether these stable growth properties of plaque VSMCs reflect altered activity of RB and/or p53. VSMCs were derived from coronary atherectomies or from normal coronary arteries from transplant recipients. Compared with normal VSMCs, plaque VSMCs showed a higher ratio of the active (hypophosphorylated) to the inactive (phosphorylated) form of RB and a lower level of E2F transcriptional activity. Cells were stably transfected with retrovirus constructs that inhibited RB or p53 alone or in combination. Suppression of RB alone increased rates of cell proliferation and apoptosis and inhibited cell senescence in normal VSMCs. Suppression of p53 and RB together had similar effects but, additionally, resulted in immortalization of normal VSMC cultures. In contrast, inhibition of RB binding to E2F or ec...Continue Reading

References

May 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·P ShawJ Costa
Apr 15, 1991·Proceedings of the National Academy of Sciences of the United States of America·D J TempletonR A Weinberg
Jun 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·D GordonS M Schwartz
Jun 21, 1991·Science·S E KernB Vogelstein
Aug 29, 1995·Proceedings of the National Academy of Sciences of the United States of America·M L AgarwalG R Stark
May 1, 1995·The Journal of Clinical Investigation·M R BennettS M Schwartz
Jun 6, 1995·Proceedings of the National Academy of Sciences of the United States of America·A AlmasanG M Wahl
Jun 6, 1995·Proceedings of the National Academy of Sciences of the United States of America·C MisseroG P Dotto
Feb 1, 1995·Molecular and Cellular Biology·X Q QinW G Kaelin
Aug 1, 1994·Genes & Development·B D DynlachtE Harlow
Dec 1, 1994·Molecular and Cellular Biology·B Shan, W H Lee
Nov 8, 1994·Proceedings of the National Academy of Sciences of the United States of America·X Q QinP D Adams
Apr 26, 1994·Proceedings of the National Academy of Sciences of the United States of America·X Wu, A J Levine
Oct 1, 1993·Molecular and Cellular Biology·K HelinA Fattaey
Dec 1, 1995·Molecular and Cellular Biology·S W HiebertJ L Cleveland
Mar 8, 1996·The Journal of Biological Chemistry·S MuthukkumarV M Rangnekar
Jan 1, 1991·Methods in Molecular Biology·J P Morgenstern, H Land

❮ Previous
Next ❯

Citations

Apr 5, 2001·Current Atherosclerosis Reports·Y J Geng
Jul 19, 2005·International Immunopharmacology·Kriti Rakesh, Devendra K Agrawal
Feb 12, 2004·Journal of Molecular and Cellular Cardiology·Tohru MinaminoIssei Komuro
Jan 25, 2003·Experimental Gerontology·Georg WickBeatrix Grubeck-Loebenstein
Jul 6, 2000·British Journal of Pharmacology·Z Mallat, A Tedgui
Jun 10, 2009·Antioxidants & Redox Signaling·Ehab H SarsourPrabhat C Goswami
Nov 11, 2009·Cardiovascular Research·José J FusterVicente Andrés
Mar 7, 2012·Cardiovascular Research·Emma YuMartin Bennett
Feb 19, 2000·Current Opinion in Lipidology·C M Shanahan, P L Weissberg
Sep 28, 2002·Current Opinion in Lipidology·Tohru Minamino, Issei Komuro
Sep 28, 2002·Current Opinion in Lipidology·Birgit C G FaberKitty B J M Cleutjens
Nov 21, 2000·Indian Heart Journal·P L Weissberg
Jan 28, 2003·Circulation Journal : Official Journal of the Japanese Circulation Society·Masao MoroiShigehiro Katayama
Nov 19, 2010·Circulation Journal : Official Journal of the Japanese Circulation Society·Tohru Minamino
Jan 24, 2015·Journal of the Science of Food and Agriculture·Kuei-Chuan ChanChau-Jong Wang
Nov 24, 2007·Biochemical Pharmacology·Charis CostopoulosMartin Bennett
Jul 2, 2003·The Journal of Pharmacy and Pharmacology·Katrina A BicknellGavin Brooks
Jun 27, 2006·Experimental and Molecular Pathology·Feng GuoWilliam D Wagner
Jan 15, 2002·Cardiology Clinics·F D KolodgieR Virmani
Jan 15, 2002·Cardiology Clinics·N McCarthyM Bennett
Jun 23, 2005·Experimental Gerontology·Jorge D Erusalimsky, David J Kurz
Jun 11, 2002·Biochemical and Biophysical Research Communications·Cécile MazièreJean-Claude Mazière
Jul 16, 2015·The Journal of Physiology·Anna K Uryga, Martin R Bennett
Aug 23, 2001·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·N V GuevaraL Chan
Apr 22, 2003·Progress in Cardiovascular Diseases·Xing Li WangJian Wang
Mar 10, 2010·Experimental Gerontology·Thomas DienerPidder Jansen-Dürr
Jan 26, 2011·European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery·K FilisF Sigala

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis